Yuen-Sum Lau
Overview
Explore the profile of Yuen-Sum Lau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pothakos K, Kurz M, Lau Y
BMC Neurosci
. 2009 Jan;
10:6.
PMID: 19154608
Background: Animal models of Parkinson's disease have been widely used for investigating the mechanisms of neurodegenerative process and for discovering alternative strategies for treating the disease. Following 10 injections with...
12.
Ahmad S, Park J, Stenho-Bittel L, Lau Y
Neurosci Lett
. 2008 Dec;
450(2):102-5.
PMID: 19084578
Loss of dopaminergic neurons in the substantia nigra (A9 cells) and ventral tegmental area (VTA) (A10 cells) has been reported in Parkinson's disease with reference to causing motor and non-motor...
13.
Li H, Armando I, Yu P, Escano C, Mueller S, Asico L, et al.
J Clin Invest
. 2008 May;
118(6):2180-9.
PMID: 18464932
Hypertension is a multigenic disorder in which abnormal counterregulation between dopamine and Ang II plays a role. Recent studies suggest that this counterregulation results, at least in part, from regulation...
14.
Banday A, Lau Y, Lokhandwala M
Hypertension
. 2007 Dec;
51(2):367-75.
PMID: 18158345
Renal dopamine plays an important role in maintaining sodium homeostasis and blood pressure (BP) during increased sodium intake. The present study was carried out to determine whether renal dopamine D1...
15.
Kurz M, Pothakos K, Jamaluddin S, Scott-Pandorf M, Arellano C, Lau Y
Neurosci Lett
. 2007 Nov;
429(1):39-42.
PMID: 17977658
The purpose of this investigation was to determine if a chronic Parkinson's disease mouse model will display less certainty in its gait pattern due to basal ganglia dysfunction. A chronic...
16.
Lau Y, Novikova L, Roels C
Neurosci Res
. 2005 Jun;
52(4):371-8.
PMID: 15936837
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is currently a leading neurotoxic agent used for producing Parkinsonism in laboratory animals. The MPTP neurotoxicity in humans is irreversible and the consequential clinical and neurochemical features closely...
17.
Garris D, Garris B, Novikova L, Lau Y
Cell Tissue Res
. 2005 Jan;
319(3):501-12.
PMID: 15672265
Expression of the diabetes (db/db) mutation in C57BL/KsJ mice results in functional suppression of the female pituitary-gonadal axis accompanied by premature utero-ovarian cytolipoatrophy. Cellular gluco- and lipo-metabolic disturbances promoted by...
18.
Lau Y, Petroske E, Meredith G, Wang J
Neuropharmacology
. 2003 Oct;
45(7):986-94.
PMID: 14573391
Long-term administration of neuroleptic drugs, such as haloperidol, in the management of psychiatric disorders may adversely cause an irreversible neurological syndrome of tardive dyskinesia, which is associated with dopamine (DA(2))...
19.
20.